Product Images Divalproex Sodium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Divalproex Sodium NDC 17856-0797 by Atlantic Biologicals Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a description of a medication called Divalproex Sodium, which is contained in a delayed-release tablet with a strength of 250 mg per tablet. The medication is only available with a prescription and should be kept out of the reach of children. The tablet comes in a unit dose packaging with one tablet per pouch and 100 tablets per case. The package insert should be consulted for indications and dosage schedules, and the medication should be stored at a temperature between 20-25°C (68-77°F). The manufacturer is identified as Migby: i Pharmaceuncar Tnduries and the distributor as Atlantic Boloicals Corp. The label contains lot numbers and an expiration date, and any questions should be directed to the manufacturer's phone number provided.*
This appears to be a figure showing the results of a study or experiment. It includes various percentages ranging from -100% to 100%, and mentions a "Reduction in CPS Rate". Without further context, it is not possible to provide a more detailed or specific description of the content.*
The text describes a figure labeled "Figure 4" that shows "Mean 4-week Migraine Rates" for two treatments, "Placebo" and "DVPX" in two different studies labeled "Study 1" and "Study 2". The specific results of the rates are not provided.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.